XBIO Return on Tangible Equity | XENETIC BIOSCIENCES, INC.

XENETIC BIOSCIENCES, INC. (XBIO) Return on Tangible Equity

2026-06-30: Return Tang Equity -40.76%.
2026-03-31: Return Tang Equity -32.14%.
2025-12-31: Return Tang Equity -36.25%.
2025-09-30: Return Tang Equity -79.78%.

Complete source-backed return tang equity history.

Available history: 2012-08-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-40.76%
2026-03-31	-32.14%
2025-12-31	-36.25%
2025-09-30	-79.78%
2025-06-30	-69.28%
2025-03-31	-71.60%
2024-12-31	-65.93%
2024-09-30	-57.94%
2024-06-30	-63.07%
2024-03-31	-51.55%
2023-12-31	-42.21%
2023-09-30	-40.81%
2023-06-30	-35.31%
2023-03-31	-45.22%
2022-12-31	-48.01%
2022-09-30	-47.59%
2022-06-30	-49.10%
2022-03-31	-34.83%
2021-12-31	-30.69%
2021-09-30	-24.81%
2021-06-30	-112.70%
2021-03-31	-101.04%
2020-12-31	-89.18%
2020-09-30	-137.38%
2020-06-30	390.04%
2020-03-31	552.17%
2019-12-31	1003.53%
2019-09-30	-146.89%
2019-06-30	288.26%
2019-03-31	675.13%
2018-12-31	279.31%
2018-09-30	98.77%
2018-06-30	-642.98%
2018-03-31	-711.61%
2017-12-31	-202.55%
2017-09-30	283.74%
2017-06-30	849.75%
2017-03-31	-3884.23%
2016-12-31	-1487.97%
2016-09-30	873.97%
2016-06-30	986.12%
2016-03-31	182.81%
2015-12-31	211.35%
2015-09-30	179.52%
2015-06-30	193.98%
2015-03-31	288.49%
2014-12-31	522.30%
2014-09-30	-4658.47%
2014-06-30	-349.29%
2014-03-31	-182.54%
2013-12-31	470.44%
2013-11-30	27.39%
2013-08-31	17.32%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	-36.25%
2024-12-31	-65.93%
2023-12-31	-42.21%
2022-12-31	-48.01%
2021-12-31	-30.69%
2020-12-31	-89.18%
2019-12-31	1003.53%
2018-12-31	279.31%
2017-12-31	-202.55%
2016-12-31	-1487.97%
2015-12-31	211.35%
2014-12-31	522.30%
2013-12-31	628.28%
2013-08-31	0.64%
2012-12-31	-89.45%
2012-08-31	95.98%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
ProPhase Labs, Inc. (PRPH)	United States	$0.006B	-0.06
Processa Pharmaceuticals, Inc. (PCSA)	United States	$0.005B
AMARIN CORP PLC\UK (AMRN)		$0.005B	-247.24
Pulmatrix, Inc. (PULM)	United States	$0.006B
Ernexa Therapeutics Inc. (ERNA)	United States	$0.006B
Dermata Therapeutics, Inc. (DRMA)	United States	$0.005B	-0.62
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)	United States	$0.005B
Cadrenal Therapeutics, Inc. (CVKD)	United States	$0.004B	-0.90
Lakewood-Amedex Biotherapeutics Inc. (LABT)	United States	$0.004B
Enveric Biosciences, Inc. (ENVB)	United States	$0.007B	-0.63